Literature DB >> 9777334

Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population.

M Naves1, A H Hajeer, L S Teh, E J Davies, J Ordi-Ros, P Perez-Pemen, M Vilardel-Tarres, W Thomson, J Worthington, W E Ollier.   

Abstract

Genetic susceptibility to systemic lupus erythematosus (SLE) may vary amongst different populations. In UK patients, genes encoded in the HLA class II (DQA*0501/DRB1*0301) and class III [C4A*Q0 and tumour necrosis factor (TNF) polymorphisms] subregions appear to contribute to disease susceptibility. We have examined HLA-DRB1, C4 and TNF microsatellites in 50 Spanish SLE patients and 48 matched controls. HLA-DRB1*0301 was increased in patients but did not achieve statistical significance (41% vs. 25.5%). C4A*Q0 was not increased in patients, but C4B*Q0 allele frequency was significantly increased compared with the controls (29% vs. 6%; OR: 6.0). TNF c2 microsatellite allele frequency was also increased in SLE patients. The C4B null allele (C4B*Q0) appears to play an important role in SLE susceptibility in the Spanish population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777334     DOI: 10.1046/j.1365-2370.1998.00110.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  9 in total

1.  Assessment of complement C4 gene copy number using the paralog ratio test.

Authors:  Michelle M A Fernando; Lora Boteva; David L Morris; Bi Zhou; Yee Ling Wu; Marja-Liisa Lokki; Chack Yung Yu; John D Rioux; Edward J Hollox; Timothy J Vyse
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

2.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Familial C4B deficiency and immune complex glomerulonephritis.

Authors:  K Soto; Y L Wu; A Ortiz; S R Aparício; C Y Yu
Journal:  Clin Immunol       Date:  2010-07-02       Impact factor: 3.969

4.  Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

Authors:  Lora Boteva; David L Morris; Josefina Cortés-Hernández; Javier Martin; Timothy J Vyse; Michelle M A Fernando
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

5.  Determination of the loss of function complement C4 exon 29 CT insertion using a novel paralog-specific assay in healthy UK and Spanish populations.

Authors:  Lora Boteva; Yee Ling Wu; Josefina Cortes-Hernández; Javier Martin; Timothy J Vyse; Michelle M A Fernando
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

6.  HLA Class III: A susceptibility region to systemic lupus erythematosus in Tunisian population.

Authors:  Hend Hachicha; Nadia Mahfoudh; Hajer Fourati; Nesrine Elloumi; Sameh Marzouk; Sawsan Feki; Raouia Fakhfakh; Faten Frikha; Abir Ayadi; Amira Maatoug; Lilia Gaddour; Feiza Hakim; Zouheir Bahloul; Hafedh Makni; Hatem Masmoudi; Arwa Kammoun
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

7.  Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis.

Authors:  Tingrui Wang; Hong Wang; Lijuan Qiu; Lingling Wu; Huayun Ling; Yu Xue; Ying Zhou; Huijuan Chen; Dong-Qing Ye; Bin Wang
Journal:  J Immunol Res       Date:  2022-04-16       Impact factor: 4.493

Review 8.  Defining the role of the MHC in autoimmunity: a review and pooled analysis.

Authors:  Michelle M A Fernando; Christine R Stevens; Emily C Walsh; Philip L De Jager; Philippe Goyette; Robert M Plenge; Timothy J Vyse; John D Rioux
Journal:  PLoS Genet       Date:  2008-04-25       Impact factor: 5.917

9.  The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians.

Authors:  Khaled Ayed; Yousr Gorgi; Saloua Ayed-Jendoubi; Rafika Bardi
Journal:  Ann Saudi Med       Date:  2004 Jan-Feb       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.